Clinical Trials · NCT05366621
Post-fracture Medication and Mortality
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- National Cheng-Kung University Hospital
- Enrollment
- 216,155
- Start date
- Nov 2020
- Locations
- 1 site, Taiwan
- Primary endpoint
- Number of deaths with and without anti-osteoporotic therapy after hip fracture surgery